Atlas Trials

Refractory Lung Adenocarcinoma

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Lung Adenocarcinoma

RecordFirmDate
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer (NCT06495125)Emory University2024-07-31
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors (NCT05733000)Northwestern University2023-03-08

Track Refractory Lung Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.